Robertson D, Goldberg M R, Tung C S, Hollister A S, Robertson R M
J Clin Invest. 1986 Aug;78(2):576-81. doi: 10.1172/JCI112611.
We studied the effects of clonidine, an alpha 2-adrenoreceptor agonist, and yohimbine, an alpha 2-adrenoreceptor antagonist, on blood pressure, heart rate, and plasma catecholamines in 12 patients with autonomic dysfunction. Clonidine (0.1 mg, orally) lowered blood pressure 18 +/- 3 torr in six subjects and raised it 5 +/- 1 torr in six. The change in blood pressure in response to this dose of clonidine was inversely proportional to the supine level of norepinephrine (P less than 0.05). Yohimbine (4-64 micrograms/kg) raised plasma norepinephrine and blood pressure in six patients with degenerative autonomic dysfunction. Yohimbine also attenuated by 50% (P less than 0.05) the hypotensive response to head-up tilt of patients with degenerative autonomic dysfunction. Clonidine depends upon postjunctional hypersensitivity and the degree of autonomic insufficiency to elicit its pressor response. In contrast, the pressor response to yohimbine is related to the capacity of the sympathetic nervous system to be activated and release norepinephrine. If plasma norepinephrine levels following yohimbine administration are monitored, the biochemical and hemodynamic response to the drug may provide a sensitive indication of the capacity of the sympathetic nervous system to be activated in patients with autonomic dysfunction.
我们研究了α2 -肾上腺素能受体激动剂可乐定和α2 -肾上腺素能受体拮抗剂育亨宾对12例自主神经功能障碍患者的血压、心率和血浆儿茶酚胺的影响。可乐定(0.1毫克,口服)使6名受试者的血压降低了18±3托,使另外6名受试者的血压升高了5±1托。对该剂量可乐定的血压变化与去甲肾上腺素的仰卧位水平呈反比(P<0.05)。育亨宾(4 - 64微克/千克)使6例退行性自主神经功能障碍患者的血浆去甲肾上腺素和血压升高。育亨宾还使退行性自主神经功能障碍患者对抬头倾斜的降压反应减弱了50%(P<0.05)。可乐定引发其升压反应取决于节后超敏反应和自主神经功能不全的程度。相比之下,对育亨宾的升压反应与交感神经系统被激活并释放去甲肾上腺素的能力有关。如果监测育亨宾给药后的血浆去甲肾上腺素水平,该药物的生化和血流动力学反应可能为自主神经功能障碍患者交感神经系统被激活的能力提供一个敏感指标。